Diabetes Mellitus Clinical Trial
Official title:
Effects of a Home-based Proprioceptive Neuromuscular Facilitation in Conjunction With Tendon Gliding Exercises on Sensorimotor Function in Upper Extremity of Subjects With Type 2 Diabetes Mellitus
Verified date | December 2018 |
Source | National Cheng-Kung University Hospital |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
In this research work, the concept of strengthening technique of proprioceptive neuromuscular facilitation (PNF) incorporated with tendon gliding exercise (TGE) will be used to improve neuromuscular function of upper extremity of patients with diabetes mellitus. The first specific aim of the study is to examine the effects of home-based PNF exercise on the motor, sensation and functional performance parameters of upper extremity of the patients with diabetes mellitus. In addition, whether adding a tendon gliding exercise (TGE) to the home-based PNF exercises can provide better treatment effects for the patients with diabetes mellitus will also been investigated in this study. One of the hypothesis of this study is the prescribing home-based PNF exercise program has a positive treatment effect on neuromuscular function of the upper extremity of patients with diabetes mellitus. And,the other is home-based PNF in conjunction with TGE provides better benefits for neuromuscular function of the upper extremity of patients with diabetes mellitus.
Status | Completed |
Enrollment | 12 |
Est. completion date | December 14, 2018 |
Est. primary completion date | August 14, 2018 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 20 Years to 80 Years |
Eligibility |
Inclusion Criteria: - Study participants will include clinically defined diabetic patients who are diagnosed based on the 1997 criteria of the American Diabetes Association. The inclusion criteria of the enrolled subjects are who suffered from neuropathy as diagnosed by abnormalities in either a nerve conduction study and / or quantitative sensory testing. Exclusion Criteria: - DM patients with (1) traumatic nerve injuries of the upper limbs, (2) trauma to the hand or congenital anomalies of the wrist and hand, (3) skin infections or disease, (4) known vascular complications of diabetes, such as stroke may have compromised the physical integrity of the patient, (5) grade 2 or higher arterial hypertension (>160/100 mmHg) or (6) cognitive deficits |
Country | Name | City | State |
---|---|---|---|
Taiwan | National Cheng-Kung University Hospital | Tainan |
Lead Sponsor | Collaborator |
---|---|
National Cheng-Kung University Hospital |
Taiwan,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change from baseline result of Semmes-Weinstein monofilament (SWM) test at 12 weeks | determine the touch-pressure threshold of the hands | pre-intervention (week 0), post-intervention (week 12) and follow-up evaluation (week 24) | |
Primary | Change from baseline result of Nerve conduction study (NCS) at 12 weeks | determine nerve condition through detection of the amplitude of the sensory and motor nerve action potential | pre-intervention (week 0) and follow-up evaluation (week 24) | |
Primary | Change from baseline result of pinch-holding-up activity test at 12 weeks | sensorimotor control of a hand | pre-intervention (week 0), post-intervention (week 12) and follow-up evaluation (week 24) | |
Primary | Change from baseline result of Purdue pegboard test at 12 weeks | determine fine fingertip dexterity | pre-intervention (week 0), post-intervention (week 12) and follow-up evaluation (week 24) | |
Primary | Change from baseline result of Minnesota Manual Dexterity Test at 12 weeks | determine unilateral and bilateral gross motor coordination of upper extremity | pre-intervention (week 0), post-intervention (week 12) and follow-up evaluation (week 24) | |
Primary | Change from baseline result of Manual tactile test at 12 weeks | determine active touching sensation | pre-intervention (week 0), post-intervention (week 12) and follow-up evaluation (week 24) | |
Secondary | Change from baseline result of Grasp and pinch power at 12 weeks | Grip strength of the hands will be assessed with a Jamar dynamometer | pre-intervention (week 0), post-intervention (week 12) and follow-up evaluation (week 24) | |
Secondary | Change from baseline result of pinch power at 12 weeks | Pinch power is measured with a pinch gauge | pre-intervention (week 0), post-intervention (week 12) and follow-up evaluation (week 24) | |
Secondary | Change from baseline result of of shoulder flexion assessing by Micro FET hand-held dynamometer at 12 weeks | Peak force of shoulder flexion (N) will be measured | pre-intervention (week 0), post-intervention (week 12) and follow-up evaluation (week 24) | |
Secondary | Change from baseline result of shoulder internal rotation assessing by Micro FET hand-held dynamometer at 12 weeks | Peak force of shoulder internal rotation (N) will be measured | pre-intervention (week 0), post-intervention (week 12) and follow-up evaluation (week 24) | |
Secondary | Change from baseline result of shoulder external rotation assessing by Micro FET hand-held dynamometer at 12 weeks | Peak force of shoulder external rotation (N) will be measured | pre-intervention (week 0), post-intervention (week 12) and follow-up evaluation (week 24) | |
Secondary | Change from baseline result of peak torque of shoulder external rotation assessing by Bi-planar isokinetic dynamometer (BID) at 12 weeks | Peak torque of shoulder external rotation (N·m) will be obtained | pre-intervention (week 0), post-intervention (week 12) and follow-up evaluation (week 24) | |
Secondary | Change from baseline result of peak torque of shoulder internal rotation assessing by Bi-planar isokinetic dynamometer (BID) at 12 weeks | Peak torque (PT) of shoulder internal rotation (N·m) will be obtained | pre-intervention (week 0), post-intervention (week 12) and follow-up evaluation (week 24) |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03743779 -
Mastering Diabetes Pilot Study
|
||
Completed |
NCT03786978 -
Pharmaceutical Care in the Reduction of Readmission Rates in Diabetes Melitus
|
N/A | |
Completed |
NCT01804803 -
DIgital Assisted MONitoring for DiabeteS - I
|
N/A | |
Completed |
NCT05039970 -
A Real-World Study of a Mobile Device-based Serious Health Game on Session Attendance in the National Diabetes Prevention Program
|
N/A | |
Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
Completed |
NCT04068272 -
Safety of Bosentan in Type II Diabetic Patients
|
Phase 1 | |
Completed |
NCT03243383 -
Readmission Prevention Pilot Trial in Diabetes Patients
|
N/A | |
Completed |
NCT03730480 -
User Performance of the CONTOUR NEXT and CONTOUR TV3 Blood Glucose Monitoring System (BGMS)
|
N/A | |
Recruiting |
NCT02690467 -
Efficacy, Safety and Acceptability of the New Pen Needle 34gx3,5mm.
|
N/A | |
Completed |
NCT02229383 -
Phase III Study to Evaluate Safety and Efficacy of Added Exenatide Versus Placebo to Titrated Basal Insulin Glargine in Inadequately Controlled Patients With Type II Diabetes Mellitus
|
Phase 3 | |
Completed |
NCT06181721 -
Evaluating Glucose Control Using a Next Generation Automated Insulin Delivery Algorithm in Patients With Type 1 and Type 2 Diabetes
|
N/A | |
Completed |
NCT05799976 -
Text Message-Based Nudges Prior to Primary Care Visits to Increase Care Gap Closure
|
N/A | |
Recruiting |
NCT04489043 -
Exercise, Prediabetes and Diabetes After Renal Transplantation.
|
N/A | |
Withdrawn |
NCT03319784 -
Analysis for NSAID VS Corticosteroid Shoulder Injection in Diabetic Patients
|
Phase 4 | |
Completed |
NCT03542084 -
Endocrinology Auto-Triggered e-Consults
|
N/A | |
Completed |
NCT02229396 -
Phase 3 28-Week Study With 24-Week and 52-week Extension Phases to Evaluate Efficacy and Safety of Exenatide Once Weekly and Dapagliflozin Versus Exenatide and Dapagliflozin Matching Placebo
|
Phase 3 | |
Recruiting |
NCT05544266 -
Rare and Atypical Diabetes Network
|
||
Completed |
NCT01892319 -
An International Non-interventional Cohort Study to Evaluate the Safety of Treatment With Insulin Detemir in Pregnant Women With Diabetes Mellitus. Diabetes Pregnancy Registry
|
||
Completed |
NCT05031000 -
Blood Glucose Monitoring Systems: Discounter Versus Brand
|
N/A | |
Recruiting |
NCT04039763 -
RT-CGM in Young Adults at Risk of DKA
|
N/A |